Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1950 1
1953 1
1964 1
1972 1
1974 4
1975 3
1976 5
1977 6
1978 4
1979 3
1980 3
1981 4
1982 3
1983 5
1984 6
1985 4
1986 3
1987 7
1988 8
1989 3
1990 2
1991 2
1992 1
1993 2
1994 3
1995 4
1996 2
1997 1
1998 2
2000 3
2001 1
2002 5
2003 5
2004 6
2005 6
2006 4
2007 5
2008 4
2009 7
2010 13
2011 7
2012 10
2013 13
2014 19
2015 17
2016 26
2017 17
2018 26
2019 16
2020 27
2021 27
2022 17
2023 20
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

368 results

Results by year

Filters applied: . Clear all
Page 1
Effect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial.
Naggie S, Boulware DR, Lindsell CJ, Stewart TG, Gentile N, Collins S, McCarthy MW, Jayaweera D, Castro M, Sulkowski M, McTigue K, Thicklin F, Felker GM, Ginde AA, Bramante CT, Slandzicki AJ, Gabriel A, Shah NS, Lenert LA, Dunsmore SE, Adam SJ, DeLong A, Hanna G, Remaly A, Wilder R, Wilson S, Shenkman E, Hernandez AF; Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV-6) Study Group and Investigators. Naggie S, et al. JAMA. 2022 Oct 25;328(16):1595-1603. doi: 10.1001/jama.2022.18590. JAMA. 2022. PMID: 36269852 Free PMC article. Clinical Trial.
Effect of Higher-Dose Ivermectin for 6 Days vs Placebo on Time to Sustained Recovery in Outpatients With COVID-19: A Randomized Clinical Trial.
Naggie S, Boulware DR, Lindsell CJ, Stewart TG, Slandzicki AJ, Lim SC, Cohen J, Kavtaradze D, Amon AP, Gabriel A, Gentile N, Felker GM, Jayaweera D, McCarthy MW, Sulkowski M, Rothman RL, Wilson S, DeLong A, Remaly A, Wilder R, Collins S, Dunsmore SE, Adam SJ, Thicklin F, Hanna GJ, Ginde AA, Castro M, McTigue K, Shenkman E, Hernandez AF; Accelerating Covid-19 Therapeutic Interventions and Vaccines (ACTIV)-6 Study Group and Investigators. Naggie S, et al. JAMA. 2023 Mar 21;329(11):888-897. doi: 10.1001/jama.2023.1650. JAMA. 2023. PMID: 36807465 Free PMC article.
Inhaled Fluticasone Furoate for Outpatient Treatment of Covid-19.
Boulware DR, Lindsell CJ, Stewart TG, Hernandez AF, Collins S, McCarthy MW, Jayaweera D, Gentile N, Castro M, Sulkowski M, McTigue K, Felker GM, Ginde AA, Dunsmore SE, Adam SJ, DeLong A, Hanna G, Remaly A, Thicklin F, Wilder R, Wilson S, Shenkman E, Naggie S; ACTIV-6 Study Group and Investigators. Boulware DR, et al. N Engl J Med. 2023 Sep 21;389(12):1085-1095. doi: 10.1056/NEJMoa2209421. N Engl J Med. 2023. PMID: 37733308 Free PMC article. Clinical Trial.
Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study.
Tabernero J, Yoshino T, Cohn AL, Obermannova R, Bodoky G, Garcia-Carbonero R, Ciuleanu TE, Portnoy DC, Van Cutsem E, Grothey A, Prausová J, Garcia-Alfonso P, Yamazaki K, Clingan PR, Lonardi S, Kim TW, Simms L, Chang SC, Nasroulah F; RAISE Study Investigators. Tabernero J, et al. Lancet Oncol. 2015 May;16(5):499-508. doi: 10.1016/S1470-2045(15)70127-0. Epub 2015 Apr 12. Lancet Oncol. 2015. PMID: 25877855 Clinical Trial.
Prion-like Spreading in Tauopathies.
Ayers JI, Giasson BI, Borchelt DR. Ayers JI, et al. Biol Psychiatry. 2018 Feb 15;83(4):337-346. doi: 10.1016/j.biopsych.2017.04.003. Epub 2017 Apr 13. Biol Psychiatry. 2018. PMID: 28506438 Free PMC article. Review.
What Is Your Diagnosis?
Lopez WA, Ayers JC, Bertran J, Fox-Alvarez SA, Vilaplana Grosso FR. Lopez WA, et al. Among authors: ayers jc. J Am Vet Med Assoc. 2022 Aug 17;261(1):1-3. doi: 10.2460/javma.22.06.0260. J Am Vet Med Assoc. 2022. PMID: 35976984 No abstract available.
Expanding spectrum of prion diseases.
Ayers JI, Paras NA, Prusiner SB. Ayers JI, et al. Emerg Top Life Sci. 2020 Sep 8;4(2):155-167. doi: 10.1042/ETLS20200037. Emerg Top Life Sci. 2020. PMID: 32803268 Review.
Guam ALS-PDC is a distinct double-prion disorder featuring both tau and Aβ prions.
Condello C, Ayers JI, Dalgard CL, Garcia Garcia MM, Rivera BM, Seeley WW, Perl DP, Prusiner SB. Condello C, et al. Among authors: ayers ji. Proc Natl Acad Sci U S A. 2023 Mar 28;120(13):e2220984120. doi: 10.1073/pnas.2220984120. Epub 2023 Mar 23. Proc Natl Acad Sci U S A. 2023. PMID: 36952379 Free PMC article.
368 results